Common Contracts
1 similar null contracts
INHIBIKASE THERAPEUTICS, INC.New York • May 17th, 2022
We have entered into an Equity Distribution Agreement, or the Equity Distribution Agreement, with Piper Sandler & Co., or Piper Sandler, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Equity Distribution Agreement, we may offer and sell shares of our common stock, $0.001 par value per share, having an aggregate offering price of up to $9,801,287 from time to time through Piper Sandler acting as our agent.
